Search clinical trials for: Boston Scientific Systems
Total 76182 results
-
New York Medical CollegeUniversity of Alabama at BirminghamRecruitingPeripheral T Cell Lymphoma | NK-Cell Lymphoma | NK-Cell LeukemiaUnited States
-
Hoffmann-La RocheGilead Sciences; Seagen Inc.RecruitingBreast CancerKorea, Republic of, Spain, United States, Israel, United Kingdom, France, Australia, Germany
-
Northwestern UniversityNational Cancer Institute (NCI); NovoCure Ltd.RecruitingAtypical Meningioma | Grade III Meningioma | Recurrent Meningioma | Anaplastic (Malignant) Meningioma | Grade II Meningioma | Supratentorial MeningiomaUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
Northwestern UniversityIntuitapCompleted
-
St. Jude Children's Research HospitalMillennium Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.Active, not recruitingMalignant Rhabdoid Tumor | Atypical Teratoid Rhabdoid TumorUnited States
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited States
-
St. Jude Children's Research HospitalAssisi FoundationCompletedLymphoma | LeukemiaUnited States
-
Northwestern UniversityTerminatedSystemic Sclerosis | SclerodermaUnited States
-
University of ArizonaNational Cancer Institute (NCI)Completed
-
CelgeneCompleted
-
Janssen Sciences Ireland UCCompleted
-
Shanghai Public Health Clinical CenterUnknownTo Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
-
Mingzhi ZhangShanxi Province Cancer Hospital; Wuhan University; Qingdao University; Wuhan Union... and other collaboratorsUnknownNasal and Nasal-type NK/T-cell LymphomaChina
-
Yale UniversityCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States, Canada
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | LeukemiaUnited States
-
National Institute of Mental Health (NIMH)Completed
-
Hellenic Institute for the Study of SepsisCompletedSepsis | Mortality | Inflammatory Response | Biomarkers | SIRS | Community-acquired PneumoniaGreece
-
Sun Yat-sen UniversityRecruitingVogt Koyanagi Harada Disease (VKH)China
-
Johns Hopkins UniversityUniversidade Federal do Rio de JaneiroTerminated
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Stanford UniversityOrca Biosystems, Inc.RecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia | Chronic Myelogenous Leukemia | Allogeneic Hematopoietic Cell Transplantation (HCT) | Advanced Hematologic MalignanciesUnited States
-
University of Southern CaliforniaVeloxis PharmaceuticalsRecruitingKidney Transplantation | Kidney Transplant RejectionUnited States
-
St. Jude Children's Research HospitalRecruitingAcute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Myeloid Sarcoma | Chronic Myeloid Leukemia (CML) | Non-Hodgkin Lymphoma (NHL) | Juvenile Myelomonocytic Leukemia (JMML)United States
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedLymphoma | Acute Leukemia | Myelodysplasia | Chronic Myelogenous Leukemia (CML)United States
-
Therapeutic Advances in Childhood Leukemia ConsortiumTakeda; Children's Hospital Los AngelesActive, not recruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Lymphoma, ChildhoodUnited States, Australia
-
Baylor College of MedicineCompletedHodgkin DiseaseUnited States
-
Stanford UniversityAstraZenecaTerminatedBladder Adenocarcinoma | Bladder Mixed Adenocarcinoma | Bladder Squamous Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma With Giant Cells | Infiltrating Bladder Urothelial Carcinoma, Nested Variant | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Bladder Urothelial... and other conditionsUnited States
-
Weill Medical College of Cornell UniversityM.D. Anderson Cancer Center; Massachusetts General Hospital; Genentech, Inc.CompletedDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Instituto Nacional de Cancer, BrazilCancer Research UK Cambridge InstituteUnknown
-
Institute of Hematology & Blood Diseases HospitalUnknownMultiple Myeloma | Plasma Cell Leukemia | Extramedullary Plasmacytoma | Loss of Chromosome 17p | t(14;16) | t(4;14) | Complex Karyotype | T(14;20) | 1Q21 AmplificationChina
-
Institute of Hematology & Blood Diseases HospitalUnknown
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Ain Shams UniversityCompletedPost Operative Pain Control
-
National Institute of Allergy and Infectious Diseases...Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Heart Center BH TuzlaUnknownPatients With Coronary Artery Disease Scheduled for by Pass SurgeryBosnia and Herzegovina
-
Asan Medical CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant NeoplasmKorea, Republic of
-
The University of Hong KongCompletedHelicobacter Pylori InfectionHong Kong
-
Assistance Publique - Hôpitaux de ParisCompletedVasculitis | Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis NodosaFrance
-
Japan Adult Leukemia Study GroupUnknownLymphoblastic Leukemia, AcuteJapan
-
PETHEMA FoundationNot yet recruitingLymphoblastic Leukemia | Adult ALL | Philadelphia-Positive ALL
-
Institute of Hematology & Blood Diseases HospitalRecruitingPrecursor Cell Lymphoblastic Leukemia-LymphomaChina
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Immunomolecular Therapeutics, Inc.WCCT GlobalCompletedType1 DiabetesUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Fanconi Anemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Aplastic AnemiaUnited States